Cecile Bonnafous

Title: The Innovative Contributions of Cecile Bonnafous

Introduction

Cecile Bonnafous is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of medical research, particularly in the treatment of peripheral T cell lymphoma. With a total of 5 patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

Cecile's latest patents include a compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma. This invention relates to methods for the treatment, prevention, and diagnosis of this type of lymphoma using compounds that specifically bind KIR3DL2. Additionally, her work includes the use of antibodies that specifically bind KIR3DL2 in diagnostic and theranostic assays for the detection and treatment of peripheral T cell lymphoma. Another notable patent involves methods for detecting tissue infiltrating NK cells, which provides methods for detecting and monitoring NK cells in paraffin-embedded tissue samples. This patent also includes antibodies, antibody fragments, and derivatives that specifically bind to NKp46 present on the surface of NK cells in these samples.

Career Highlights

Cecile has worked with notable companies in the biotechnology sector, including Innate Pharma. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer treatment.

Collaborations

Cecile has collaborated with esteemed colleagues such as Helene Sicard and Renaud Buffet. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.

Conclusion

Cecile Bonnafous is a remarkable inventor whose work in the field of medical research is paving the way for new treatments for peripheral T cell lymphoma. Her innovative patents and collaborations highlight her dedication to improving patient outcomes.